UPDATE 1-GSK sells Europe OTC brands to Omega, Alli delayed

Posted on March 15, 2012 at 06:03 AM EDT

LONDON, March 15 - GlaxoSmithKline has agreed to sell a collection of over-the-counter healthcare brands in Europe to Omega Pharma for 470 million euros ($612 million), while delaying the divestment of weight-loss pill Alli.

Related Stocks:

GlaxoSmithKline PLC ADS Johnson & Johnson Prestige Brands Holdings, Inc. Procter & Gamble Co. RECKITT BENCK GRP

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates